Company profile

Bioheng company profile

BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed and automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
400-828-8076
Operating status
Active
Company type
For Profit
Employee range
00101-00250 employees
Revenue range
$10K+
Founded
2017-01-01

Headquarters

Headquarters
Ning’er, Yunnan, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
3
Total equity funding
$124.5M
Last funding
Series C / $30M / 2024-11-29
Last equity funding
Series C / $30M
Investors
7
Lead investors
2
Founders
1
Articles
3

Founders and investors

Founders

Xiaohong He

Lead investors

Decheng CapitalGL Ventures LLC

Investors

Decheng CapitalHillhouse InvestmentOctagon Capital AdvisorsQiming Venture PartnersShenzhen Capital Group

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.